Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells.
Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells.
复制标题
2 型糖尿病患者血小板上胶原蛋白受体 Fc 受体-γ/糖蛋白 VI 的表面表达增强,并介导 CD40 配体的释放和内皮细胞的激活。
作者:
N. Cabeza;Zhongyan Li;C. Schulz;E. Kremmer;S. Massberg;A. Bültmann;M. Gawaz
Diabetes is associated with an enhanced collagen-mediated platelet activation that contributes significantly to thromboischemic complications. In this study, the platelet collagen receptor glycoprotein VI (GPVI) was studied in 385 patients with type 2 diabetes. Surface expression of the platelet Fc receptor that forms a functional complex with GPVI was significantly increased in patients with diabetes compared with those without diabetes (P = 0.02). Fc receptor expression correlated with GPVI expression and was found to be independently associated with diabetes (r = 0.529, P < 0.001). Stimulation of GPVI through a specific anti-GPVI monoclonal antibody significantly enhanced surface expression of CD40L (P = 0.006). Because CD40L is a potent platelet-derived cytokine that is involved in thrombosis and atherosclerosis, we evaluated the effect of GPVI-mediated release of CD40L on activation of endothelial cells. Coincubation of GPVI-stimulated platelets resulted in substantial enhanced endothelial surface expression of CD62P, alphavbeta3, and intercellular adhesion molecule 1 (P < 0.05) and secretion of monocyte chemoattractant protein 1 of cultured human umbilical vein endothelial cells (P < 0.01). These results suggest that the function of collagen receptor GPVI is altered in type 2 diabetes and may play an important role in atherothrombotic complications. Inhibition of GPVI may be a promising pharmacological target in the treatment of high-risk diabetic patients.
登录
查看更多内容
DOI:
10.1073/pnas.97.13.7458
发表时间:
2000-06-20
影响因子:
11.1
作者:
Schönbeck, U;Sukhova, GK;Libby, P
通讯作者:
Libby, P
DOI:
--
发表时间:
1981
期刊:
The Journal of laboratory and clinical medicine
影响因子:
--
作者:
Halushka,PV;Rogers,RC;Loadholt,CB;Colwell,JA
通讯作者:
Colwell,JA
DOI:
10.1016/s0002-9440(10)63648-6
发表时间:
2003
期刊:
The American journal of pathology
影响因子:
--
作者:
Yamashiro,Kenji;Tsujikawa,Akitaka;Ishida,Susumu;Usui,Tomohiko;Kaji,Yuichi;Honda,Yoshihito;Ogura,Yuichiro;Adamis,AnthonyP
通讯作者:
Adamis,AnthonyP
DOI:
10.1016/s0735-1097(01)01555-8
发表时间:
2001-11-01
影响因子:
24
作者:
Osende, JI;Badimon, JJ;Crandall, JP
通讯作者:
Crandall, JP